Higher food and energy prices are keeping inflation risks alive in nearby Asian economies, and central banks are holding rates steady rather than rushing to cut. That keeps money tight and rewards businesses that can grow without leaning heavily on cheap debt. Australian high growth potential stocks that already have healthier balance sheets fit neatly into this backdrop. This article highlights three of the strongest candidates from that group.
The three Australian examples below are only a...
The Australian sharemarket is poised for a positive start, buoyed by gains in global markets and easing inflation pressures, although local investors remain mindful of potential interest rate changes and geopolitical developments. Amidst this backdrop, penny stocks—often representing smaller or newer companies—continue to capture attention for their affordability and growth potential. Despite the term's somewhat outdated feel, these stocks can offer surprising value when backed by strong...
Oil flows from the Middle East remain surprisingly strong despite recent attacks on Saudi infrastructure, which keeps global energy supply in focus for Australian investors. Reliable power sources appear more important when conflict risk lingers around key shipping routes. Nuclear energy stocks offer one way to gain exposure to long term electricity demand. This article highlights three Australian nuclear related stocks from our screener that investors may want to add to their watchlist.
The...
Central banks are lifting interest rates to tackle sticky inflation, which puts pressure on highly leveraged businesses but can reward investors who focus on real cash being generated today. Australian companies that throw off solid cash flows yet trade below their estimated fair value can offer a rare combination of resilience and potential upside. This article profiles three such stocks that screen well on discounted cash flow metrics.
The three stocks highlighted below are a small sample...
In recent months, the Asian markets have experienced a mix of volatility and growth, with small-cap stocks in particular facing challenges amid fluctuating economic indicators and broader market sentiment. As investors navigate these conditions, identifying stocks with strong fundamentals and insider buying can offer valuable insights into potential opportunities within the small-cap sector.
EVT Limited (ASX:EVT) has begun a wide-ranging review of its group structure after flagging around A$800 million of non core property for possible sale, a move closely watched by investors.
EVT shares have shown mixed momentum into this announcement. The 1 day share price return of 1.66% and year to date share price gain of 7.08% contrast with a 30 day share price return that is down 4.40%. The 3 year total shareholder return of 32.93% points to a stronger longer run track record than the 1...
Index removal puts Orora in focus
Orora (ASX:ORA) has been dropped from the FTSE All-World Index, a change that can prompt passive funds to adjust positions and often creates trading swings that are unrelated to the company’s underlying packaging operations.
At A$1.405, Orora’s recent index exit comes after a share price that has fallen 36.71% year to date and a 1 year total shareholder return that declined 29.64%. A 3.31% 90 day share price gain hints that momentum has recently stabilised...
As the Australian sharemarket faces a softer start to the week, with ASX 200 futures indicating a slight decline, investors are keenly observing how global rate hikes and local economic signals will influence market dynamics. In this environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong internal confidence and alignment of interests between management and shareholders.
The Australian sharemarket is experiencing a mixed start to the week, with global market volatility and interest rate concerns influencing investor sentiment. Amid these fluctuating conditions, penny stocks remain an intriguing option for investors seeking growth opportunities at lower price points. Despite their vintage name, penny stocks can offer significant potential when backed by strong financials and solid fundamentals, providing a unique blend of value and growth prospects in today's...
Cochlear has appointed Professor Ian Meredith AM as an independent Non executive Director, effective 1 December 2026. This appointment adds over 30 years of clinical research, medical device and healthcare commercialisation experience to the Board.
His background leading medical affairs and technology evaluation for a broad portfolio at Boston Scientific, along with current board roles at cardiovascular device developers, directly relates to Cochlear’s product pipeline, R&D governance and...
Higher long term interest rates in the US are reshaping how money is priced around the world, and that includes Australian growth stories. Expensive debt can make slower businesses feel the strain, while fast growing companies with high insider ownership may still push ahead using retained cash and aligned management. This article looks at three such Australian stocks that fit that profile and explains what makes each one worth a closer look.
The stocks covered next are only a small sample,...
Rising long term interest rates are forcing investors to rethink how they generate income from their portfolios. Term deposits and cash now look more appealing, yet they do not offer the potential for growing payouts over time. Well covered Australian dividend stocks paying more than 3% can help fill that gap. This article highlights three income ideas from this higher yield, quality focused group.
The three dividend ideas below are only a sample from this higher yield group, as the full...
Telix Pharmaceuticals (ASX:TLX) has moved to lead a merger with ITM Isotope Technologies Munich SE, outlining plans for a combined radiopharmaceutical group that spans isotope production, manufacturing and commercial distribution.
Despite the merger announcement knocking the share price down by about 11.7% on the day to A$15.76, Telix Pharmaceuticals still carries a 38.7% year to date share price gain. Long term holders have seen total shareholder returns of 167.1% over five years, hinting...
The Federal Reserve keeps lifting interest rates as big tech pours money into AI infrastructure, which puts artificial intelligence at the center of global policy debates and corporate budgets. That mix creates a window for Australian AI related stocks that appear inexpensive on traditional valuation screens. This article walks through three AI shares from our screener that may merit a closer look at this time.
The three Australian AI stocks below are a sample from a wider hunting ground, and...
Rare earth magnets sit quietly inside everything from EV motors to missile systems, so a double hit of falling Chinese exports to the US and tighter export licenses is not just a trade story; it is a supply shock story. That squeeze can shift pricing power and reshape which companies gain or lose. This piece explains the backdrop and then highlights 3 stocks exposed to this news so you can assess where the risk and potential lie.
The three stocks below are just a starting sample. The full...
Long term interest rates have surged as central banks signal a world of higher borrowing costs, which puts pressure on weaker balance sheets and rewards companies that keep their finances in order. For Australian penny shares, that creates a clear filter. Investors who focus on smaller businesses with healthier numbers can avoid some of the wildest swings. This article highlights three such low priced stocks from our financially robust penny share screen.
The three stocks that follow are only...
ASX Limited has reshaped its executive ranks, appointing Keir Barnes as CFO, Mark Peterson as Managing Director, Clearing and Settlement, and Elaine Vaisanen as COO, all bringing multi decade capital markets and operations experience from Dexus, NZX, and J.P. Morgan.
The new leadership mix concentrates deep clearing, settlement, and operations expertise at ASX, which is central to technology modernisation, regulatory engagement, and the large scale transformation program known as...
Minerals 260 recently filed follow on equity offerings totaling A$280,000,001 at A$0.88 per ordinary share, alongside an activities update on its Bullabulling Gold Project in Western Australia.
The sizeable capital raise points to significant funding needs for Bullabulling and related work programs. This highlights potential pressure on project execution costs and future development decisions.
The focus now shifts to how Minerals 260's large equity raising shapes the investment narrative and...
Long term interest rates have been climbing as investors react to changing expectations around central bank policy. That move is putting more pressure on highly leveraged businesses and on companies that rely on cheap capital. Founder led Australian stocks can look different in this setting, because leadership often treats the business more like a personal legacy than a short term job. This article highlights three such companies from our screener.
The three founder led stocks below are just...